SGYP News and Press, Synergy Pharmaceuticals Inc. From 01/27/19

Amarin ( AMRN ) has been a darling of biotech investors with one of the highest bullish sentiments that I have seen on a stock. I will not go into the details of the background of this stock since I assume that you are familiar with it. Amarin's sole product Vascepa has a proprietary formulati...

HENDERSON, NV / ACCESSWIRE / January 25, 2019 / Below are some of the best small-micro cap opportunities on the market today. One that may want to look at right away is Gopher Protocol Inc. (GOPH) , an Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies company...

Investors in Synergy Pharmaceuticals ( SGYP ) have recently been extremely disappointed by the lack of communication and understanding about what's been happening inside the company. The company has gone in silent mode and that has a lot of investors fretting about what the future might look l...

NEW YORK, Aug. 31, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Sykes Enterprises, Incorporated (NASDAQ:SYKE), Carnival Corporation (NYSE...

The Synergy Investment Group , a group of over 1,030 investors who have claimed to collectively own 37.5 million shares in Synergy Pharmaceuticals ( SGYP ) is losing no time to pick a new target after its victory on defeating shareholder-unfriendly proposals. This time the group is going afte...

Synergy Pharmaceuticals ( SGYP ) CEO Troy Hamilton is quickly proving to be a very capable CEO and is proving skeptics that he understands what's needed to be done to turn the company around. In order for the share price to recover, three things needed to happen: Insurance wins, cash burn re...